Novel cariprazine-derived D2/5-HT3 receptor modulators with potential impact on the treatment of schizophrenia and depressive symptoms
Basic information
Investigator: Mgr. Radomír Jůza, Ph.D.
Main recipient: National Institute of Mental Health (NIMH)
Co-recipient: n/a
Research period:
Total budget: 5 277 000 CZK
NIMH budget: 5 277 000 CZK
Supported by: The Czech Science Foundation (GACR)